Yahoo
BSE - Delayed Quote INR

Makers Laboratories Limited (MAKERSL.BO)

222.60 +0.15 (+0.07%)
At close: 3:20:55 PM GMT+5:30
Chart Range Bar
Loading chart for MAKERSL.BO
  • Previous Close 222.45
  • Open 210.05
  • Bid 220.00 x --
  • Ask 224.95 x --
  • Day's Range 210.05 - 229.00
  • 52 Week Range 109.00 - 239.00
  • Volume 520
  • Avg. Volume 3,013
  • Market Cap (intraday) 1.313B
  • Beta (5Y Monthly) 0.17
  • PE Ratio (TTM) 38.45
  • EPS (TTM) 5.79
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est --
  • Moby Rating Neutral

Makers Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations in India. It operates in two segments, Pharmaceutical and Chemical Manufacturing. The company offers general health therapeutic products, including acid regulatory, anthelmintic, anti-allergic, anti-asthmatic, anti-biotic, anti-diabetics, anti-diarrhoeals, anti-emetics and anti-nauseants, anti-fungal, anti-hypertensive, anti–inflammatory, analgesic, anti-spasmodic, anti-malarial, and anti-thyroid. It also provides cough and cold control, digestives, neurotonics, nutritional supplements, topical anti-biotic/anti-microbial, and other specialty drugs. The company sells its products under the Duramol, Artemak-AB, Loroquin, Nimuwin, Coffwin, and Exylin brands. It distributes its products through agents, stockiest, doctors, and retailers. The company also exports its products. Makers Laboratories Limited was incorporated in 1984 and is based in Mumbai, India.

www.makerslabs.com

114

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

MAKERSL.BO
88.40%
S&P BSE SENSEX (^BSESN)
4.95%

1-Year Return

MAKERSL.BO
76.67%
S&P BSE SENSEX (^BSESN)
2.66%

3-Year Return

MAKERSL.BO
102.36%
S&P BSE SENSEX (^BSESN)
24.66%

5-Year Return

MAKERSL.BO
10.50%
S&P BSE SENSEX (^BSESN)
33.78%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY18
Revenue 116.52M
Earnings -1.56M
Profit Margin -1.34%

Q1

FY16

Q2

FY16

Q4

FY17

Q1

FY18

0
50M
100M
150M
0.0%
2.0%
4.0%
6.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.30%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    1.49B

  • Net Income Avi to Common (ttm)

    34.19M

  • Diluted EPS (ttm)

    5.79

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    117.71M

  • Total Debt/Equity (mrq)

    5.00%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: